These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6641030)

  • 1. Fc-receptor function in minimal change nephrotic syndrome of childhood.
    Davin JC; Foidart JB; Mahieu PR
    Clin Nephrol; 1983 Dec; 20(6):280-4. PubMed ID: 6641030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc-receptor function in Henoch-Schönlein disease of childhood.
    Davin JC; Foidart JB; Mahieu PR
    Proc Eur Dial Transplant Assoc; 1983; 19():590-6. PubMed ID: 6553913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Fc-receptor blocking factors in IgA nephropathies.
    Roccatello D; Coppo R; Piccoli G; Cordonnier D; Martina G; Rollino C; Picciotto G; Sena LM; Amoroso A
    Clin Nephrol; 1985 Apr; 23(4):159-68. PubMed ID: 3874036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
    Arend WP; Massoni RJ
    Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
    Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor T-lymphocyte dysfunction in MCNS: role of the H2 histamine receptor-bearing suppressor T lymphocytes.
    Inage Z; Wada N; Kikkawa Y; Inami M; Hirose H; Kitagawa T
    Clin Nephrol; 1990 Jan; 33(1):20-4. PubMed ID: 2137404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell subpopulations in childhood nephrotic syndrome.
    Kobayashi K; Yoshikawa N; Nakamura H
    Clin Nephrol; 1994 May; 41(5):253-8. PubMed ID: 8050203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in minimal change nephrotic syndrome.
    Tina LU; Phillips TM; Calcagno PL
    Int J Pediatr Nephrol; 1984 Jun; 5(2):63-6. PubMed ID: 6386721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte and macrophage Fc-receptor function in systemic vasculitis with renal involvement.
    Roccatello D; Coppo R; Rollino C; Martina G; Piccoli G; Sena LM
    Int J Tissue React; 1984; 6(6):541-5. PubMed ID: 6530356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.
    Kurlander RJ; Ellison DM; Hall J
    J Immunol; 1984 Aug; 133(2):855-62. PubMed ID: 6736648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human macrophage function in cancer: systemic and local changes detected by an assay for Fc receptor expression.
    Rhodes J; Plowman P; Bishop M; Lipscomb D
    J Natl Cancer Inst; 1981 Mar; 66(3):423-9. PubMed ID: 6937700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-mediated inhibition of lymphocyte Fc gamma receptors in glomerulonephritis.
    Bakkaloglu A; Sandilands GP; Briggs JD; Anderson JR
    Clin Exp Immunol; 1980 Dec; 42(3):490-4. PubMed ID: 6111406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of functional complement receptors during in vitro maturation of human monocytes into macrophages.
    Newman SL; Musson RA; Henson PM
    J Immunol; 1980 Nov; 125(5):2236-44. PubMed ID: 7430626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
    Hurst NP; Nuki G; Wallington T
    Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I typing in Egyptian childhood minimal change nephrotic syndrome.
    Donia AF; Ismail AM; Moustafa Fel-H
    J Nephrol; 2008; 21(5):734-7. PubMed ID: 18949728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypan blue inhibition of complement receptor function on various cells.
    Harper BL; Fine DP; Guckian JC; Cavallo T
    Immunology; 1981 Jan; 42(1):61-6. PubMed ID: 7461725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor associated defects of cultured monocytes in bronchial carcinoma.
    Lukacs K; Carroll MP; Hodson ME; Kay AB
    Clin Exp Immunol; 1984 May; 56(2):321-9. PubMed ID: 6733974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antibody-dependent phagocytosis of lipid vesicles by RAW264 macrophages results in the loss of cell surface Fc but not C3b receptor activity.
    Petty HR; Hafeman DG; McConnell HM
    J Immunol; 1980 Dec; 125(6):2391-6. PubMed ID: 7430632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid effects on minimal lesion nephrotic syndrome with and without immune deposits.
    Kim PK; Kim NA; Kim KS; Choi IJ
    Int J Pediatr Nephrol; 1982 Dec; 3(4):257-61. PubMed ID: 7166452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.